HOME >> BIOLOGY >> NEWS
Drugs from the deep blue

For Tadeusz Molinski, the sea is full of riches -- and he does not mean oil fields or fisheries. Molinski, a professor of chemistry at the University of California, Davis, is searching for new treatments for cancer, infectious diseases and other conditions that could be made from natural products in the soft bodies of some of the ocean's simplest inhabitants.

"Three quarters of the world is covered by oceans, and we've only dipped below the surface," Molinski said.

This chemist sees natural products from marine organisms as an opportunity to answer questions in biology and find potential leads for the next generation of drugs, whether those are anti-fungals or treatments for cancer. Many pharmaceutical drugs on the market, from aspirin to cholesterol-lowering "statins," are derived from natural products such as plants or bacteria. Molinski says modern developments in analytical chemistry, including highly sensitive instrumentation, sophisticated screening capabilities and discoveries from mapping the human genome, have created a renaissance of interest in these sources of potential medicines.

Molinski's laboratory studies the chemistry and biology of marine natural products, or chemical compounds made by sea creatures. It is part of a developing focus on pharmaceutical chemistry within the UC Davis chemistry department, including research on biologically active molecules and high-throughput screening techniques.

Most of Molinski's samples come from sponges and tunicates, marine creatures that can neither swim away from a diver nor bite. Recently, the researchers have also begun to collect samples from cyanobacteria, single-celled organisms that occur as slimy mats or filaments in places such as coral reefs and mangrove lagoons.

Some of these compounds have biochemical activities that could be useful in medicine -- killing microbes, stopping growth of cancer cells, or affecting the flow of calcium in and out of cells.

Mari
'"/>

Contact: Andy Fell
ahfell@ucdavis.edu
530 752-4533
University of California - Davis
1-Jun-2005


Page: 1 2 3 4

Related biology news :

1. Eleven million Euros for Endotrack
2. Molecular signature protects cells from viruses
3. Novel molecular signature marks DNA of embryonic stem cells
4. Common molecular signature identified in solid tumors
5. Gene predicts better outcome as cortex normalizes in teens with ADHD
6. Marker predicts pancreatic cancer outcome after surgery, Jefferson surgeon finds
7. Major study predicts grim future for Europes seas
8. FDG-PET imaging clearly predicts lung cancer patients response to chemotherapy
9. NASA predicts nongreen plants on other planets
10. Gene profiling predicts resistance to breast cancer drug Herceptin
11. Mathematical model predicts cholera outbreaks

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/6/2019)... ... June 05, 2019 , ... Ziegler, ... financial advisor to Pathologists Bio-Medical Laboratories (PBM) on its recent acquisition by PathGroup. ... platform that provides services to more than one dozen hospitals and surgery centers ...
(Date:6/4/2019)... Calif. (PRWEB) , ... June 04, 2019 , ... Harper ... was limping. X-rays revealed severe elbow dysplasia, which caused painful osteoarthritis in the ... her elbows. Her parents were heartbroken. , The surgical specialist, Dr. Christopher Eich ...
(Date:6/3/2019)... ... ... Stay on top of current hot topics through free webinars presented by ... is free, so be sure to register today to save your place! Participate in ... see our upcoming webinars: , CLINICAL TRIALS , June 10 – A Novel Approach ...
Breaking Biology News(10 mins):
(Date:5/31/2019)... , ... May 30, 2019 , ... ... thinking on Data Integrity on July 08-09, 2019 in Boston, MA. This peer ... and medical device organizations. , The training will kick off with a compendial ...
(Date:5/21/2019)... ... May 21, 2019 , ... ... today officially opened the inaugural Africa Brewing Conference dedicated to sharing brewing knowledge, ... Africa. The event, which is supported through a partnership with “Ethiopia Invest”, will ...
(Date:5/14/2019)... ... , ... Gateway Genomics , a leading developer of prenatal and pediatric ... square feet. , “This past year has seen exponential growth for the sales ... Jacob. “The SneakPeek At-Home test, which is mailed directly to our customers who self-collect ...
(Date:5/4/2019)... ... May 03, 2019 , ... ... of the Diopsys® ffERG/Photopic Negative Response vision test, a new full ... 2050, it is estimated that 6.3 million Americans will have glaucoma, with black ...
Breaking Biology Technology:
Cached News: